Search
forResearch 10 of 1000+
- A novel microparticle based formulation for topical delivery of FOL-005, a small peptide
- 128 Analysis of mice skin distribution using MALDI-MSI after subcutaneous injections of a potent novel peptide hair growth promoter, FOL-005
- 201 Analysis of mice skin distribution using MALDI-MSI after subcutaneous injections of a new potent novel inhibitor of human hair growth, FOL-005
- 695 Using MALDI-MSI analysis to study distribution of FOL-005, a potent, novel inhibitor of human hair growth, after subcutaneous injection in mice
- An osteopontin‐derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor‐7 production in outer root sheath keratinocytes
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Osteopontin regulatory functions in the hair follicle open a therapeutic approach for hypertrichosis
- 130 Expression of nidogen1 in basal cell carcinoma
- 131 Mutational landscape of extramammary Paget disease
- 1371 FGF7-dependent inhibition of human hair growth byan osteopontin-derived peptide: A novel solution for hirsutism and hypertrichosis?
Community 5
- Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
- Peptides that Stop Hair Loss? | In-depth Literature Review Video
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- What to look Forward to in 2025
- He used Dutasteride for 20 YEARS: TL;DR Slight gains and largely stable for 20 years.
Learn
— no results
Try a deeper search in learn →